DNA damage-induced inhibition of securin expression is mediated by p53. (Q44196770)

30 November 2017

DNA damage-induced inhibition of securin expression is mediated by p53. (English)

1 reference

30 November 2017

Yunli Zhou

1

1 reference

30 November 2017

Kshama R Mehta

2

1 reference

30 November 2017

Andrew P Choi

3

1 reference

30 November 2017

Staci Scolavino

4

1 reference

30 November 2017

Xun Zhang

5

1 reference

30 November 2017

language of work or name

English

0 references

publication date

25 October 2002

1 reference

Journal of Biological Chemistry

30 November 2017

9

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

30 November 2017

278

1 reference

30 November 2017

462-470

1 reference

30 November 2017

1

1 reference

Anaphase initiation in Saccharomyces cerevisiae is controlled by the APC-dependent degradation of the anaphase inhibitor Pds1p

30 November 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203793200

Cut2 proteolysis required for sister-chromatid seperation in fission yeast

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203793200

Separation of sister chromatids in mitosis requires the Drosophila pimples product, a protein degraded after the metaphase/anaphase transition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203793200

Identification of a vertebrate sister-chromatid separation inhibitor involved in transformation and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203793200

Disseminating the genome: joining, resolving, and separating sister chromatids during mitosis and meiosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203793200

Securin is required for chromosomal stability in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203793200

The anaphase inhibitor of Saccharomyces cerevisiae Pds1p is a target of the DNA damage checkpoint pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203793200

Pds1p, an inhibitor of anaphase in budding yeast, plays a critical role in the APC and checkpoint pathway(s).

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203793200

Pds1 phosphorylation in response to DNA damage is essential for its DNA damage checkpoint function

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203793200

The DNA damage response: putting checkpoints in perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203793200

Genetic instabilities in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203793200

Regulation of p53 in response to DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203793200

The evolution of diverse biological responses to DNA damage: insights from yeast and p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203793200

Regulation of p53 downstream genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203793200

A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203793200

DNA damage and mutagenesis by radiomimetic DNA-cleaving agents: bleomycin, neocarzinostatin and other enediynes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203793200

Structure, expression, and function of human pituitary tumor-transforming gene (PTTG)

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203793200

Cell cycle regulated expression and phosphorylation of hpttg proto-oncogene product

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203793200

Disruption of p53 in human cancer cells alters the responses to therapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203793200

DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203793200

Mdm2 promotes the rapid degradation of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203793200

Regulation of p53 stability by Mdm2

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203793200

Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203793200

Nucleolar Arf sequesters Mdm2 and activates p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203793200

p53 negatively regulates cdc2 transcription via the CCAAT-binding NF-Y transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203793200

A survey of 178 NF-Y binding CCAAT boxes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203793200

A quantitative analysis of nuclear factor I/DNA interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203793200

The molecular biology of the CCAAT-binding factor NF-Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203793200

NPAT links cyclin E-Cdk2 to the regulation of replication-dependent histone gene transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203793200

21 January 2018

Surfing the p53 network

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203793200

Regulation of the G2/M transition by p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203793200

Cyclin A expression is under negative transcriptional control during the cell cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203793200

The cyclin B2 promoter depends on NF-Y, a trimer whose CCAAT-binding activity is cell-cycle regulated

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203793200

Xenopus NF-Y pre-sets chromatin to potentiate p300 and acetylation-responsive transcription from the Xenopus hsp70 promoter in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203793200

NF-Y is associated with the histone acetyltransferases GCN5 and P/CAF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203793200

Isolation and characterization of the human A-myb promoter: regulation by NF-Y and Sp1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203793200

Sp1 and NF-Y synergistically mediate the effect of vitamin D(3) in the p27(Kip1) gene promoter that lacks vitamin D response elements

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203793200

Functional interaction of NF-Y and Sp1 is required for type a natriuretic peptide receptor gene transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203793200

NF-Y and Sp1 cooperate for the transcriptional activation and cAMP response of human tissue inhibitor of metalloproteinases-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203793200

Major histocompatibility complex class II-associated invariant chain gene expression is up-regulated by cooperative interactions of Sp1 and NF-Y.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203793200

The B subunit of the CAAT-binding factor NFY binds the central segment of the Co-activator p300.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203793200

Assembly of recombinant TFIID reveals differential coactivator requirements for distinct transcriptional activators

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203793200

Mechanism of rapid transcriptional induction of tumor necrosis factor alpha-responsive genes by NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203793200

Securin is not required for cellular viability, but is required for normal growth of mouse embryonic fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203793200

Dual inhibition of sister chromatid separation at metaphase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203793200

Isolation and characterization of a pituitary tumor-transforming gene (PTTG)

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203793200

Identification of c-myc as a down-stream target for pituitary tumor-transforming gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203793200

Human pituitary tumor-transforming gene induces angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203793200

Human securin, hPTTG, is associated with Ku heterodimer, the regulatory subunit of the DNA-dependent protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203793200

The DNA-dependent protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203793200

Ku acts in a unique way at the mammalian telomere to prevent end joining

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203793200

Effects of DNA nonhomologous end-joining factors on telomere length and chromosomal stability in mammalian cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203793200

Truncated Activin Type I Receptor Alk4 Isoforms Are Dominant Negative Receptors Inhibiting Activin Signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203793200

NF-Y Recruitment of TFIID, Multiple Interactions with Histone Fold TAFIIs

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203793200

Control of the DNA damage checkpoint by chk1 and rad53 protein kinases through distinct mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203793200

Downregulation of telomerase reverse transcriptase mRNA expression by wild type p53 in human tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203793200

Regulation of the human hsp70 promoter by p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203793200

NF-Y mediates the transcriptional inhibition of the cyclin B1, cyclin B2, and cdc25C promoters upon induced G2 arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203793200

Transcriptional regulation of the human cystathionine beta-synthase -1b basal promoter: synergistic transactivation by transcription factors NF-Y and Sp1/Sp3

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203793200

Cooperative binding of NF-Y and Sp1 at the DNase I-hypersensitive site, fatty acid synthase insulin-responsive element 1, located at -500 in the rat fatty acid synthase promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203793200

p300 collaborates with Sp1 and Sp3 in p21(waf1/cip1) promoter activation induced by histone deacetylase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203793200

Determination of cell fate by c-Abl activation in the response to DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203793200

21 January 2018

Identifiers

DOI

10.1074/JBC.M203793200

1 reference

30 November 2017

1 reference